Vimarsana
Biggest News Aggregation in the World

Page 5 - Nasdaq Tern News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Tern. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Tern Today - Breaking & Trending Today

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives $16.11 Average PT from Brokerages - Vimarsana News

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives $16.11 Average PT from Brokerages

Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Free Report) has been assigned an average rating of “Moderate Buy” from the nine research firms that are covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12 month price objective […]

Terns Pharmaceuticals (NASDAQ:TERN) Trading Up 5.9% - Vimarsana News

Terns Pharmaceuticals (NASDAQ:TERN) Trading Up 5.9%

Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Free Report)’s stock price was up 5.9% during mid-day trading on Friday . The stock traded as high as $9.01 and last traded at $8.97. Approximately 440,929 shares were traded during trading, a decline of 17% from the average daily volume of 528,878 shares. The stock had previously closed at […]

Terns Pharmaceuticals (NASDAQ:TERN) Coverage Initiated at Mizuho - Vimarsana News

Terns Pharmaceuticals (NASDAQ:TERN) Coverage Initiated at Mizuho

Research analysts at Mizuho started coverage on shares of Terns Pharmaceuticals (NASDAQ:TERN – Get Rating) in a research report issued on Thursday, The Fly reports. The firm set a “buy” rating and a $16.00 price target on the stock. Mizuho’s price target suggests a potential upside of 46.25% from the company’s current price. A number […]

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives Consensus Recommendation of "Moderate Buy" from Analysts - Vimarsana News

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Rating) has earned a consensus recommendation of “Moderate Buy” from the eight analysts that are presently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 12-month price objective among brokerages […]

Terns Pharmaceuticals (NASDAQ:TERN) Now Covered by Roth Mkm - Vimarsana News

Terns Pharmaceuticals (NASDAQ:TERN) Now Covered by Roth Mkm

Roth Mkm started coverage on shares of Terns Pharmaceuticals (NASDAQ:TERN – Get Rating) in a research report sent to investors on Wednesday morning, Briefing.com reports. The firm issued a buy rating and a $23.00 price objective on the stock. A number of other equities analysts also recently commented on TERN. HC Wainwright lifted their target […]